After-hours 16:02 (ET)TVTX Latest Quarter’s Earnings
Announce Date11/2/2026
EPS Actual (USD)-0.55
Revenue Actual (USD)224.56M
Travere Therapeutics Inc Earnings Dates & Reports
This page offers detailed Travere Therapeutics Inc earnings data including the latest Travere Therapeutics Inc earnings report, the upcoming Travere Therapeutics Inc earnings date, historical data and Travere Therapeutics Inc earnings call news.
TVTX Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
TVTX FY2025 Earnings
EPS (YoY)-0.2992.97%
Revenue (YoY)490.73M110.45%
Travere Therapeutics Inc (TVTX) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 11/2/2026 | 09/2026 | -0.55/-0.06 | 224.56M/195.29M | -870.32% | 14.99% |
| 8/4/2026 | 06/2026 | -0.37/-0.14 | 169.58M/159.59M | -168.28% | 6.26% |
| 5/4/2026 | 03/2026 | -0.40/-0.27 | 127.20M/136.28M | -52.08% | -6.67% |
| 2/19/2026 | 12/2025 | 0.03/-0.12 | 129.69M/142.24M | 125.61% | -8.82% |
| 10/30/2025 | 09/2025 | 0.29/-0.21 | 164.86M/106.53M | 238.62% | 54.75% |
| 8/6/2025 | 06/2025 | -0.14/-0.30 | 114.45M/100.64M | 51.84% | 13.72% |
| 5/1/2025 | 03/2025 | -0.47/-0.54 | 81.73M/75.53M | 13.59% | 8.21% |
| 2/20/2025 | 12/2024 | -0.72/-0.56 | 74.79M/73.34M | -28.92% | 1.98% |
Travere Therapeutics Inc Latest Earnings Call Transcripts
Travere Therapeutics (TVTX) Q3 2026 Earnings Call: FILSPARI Sales Reach $200.2 Million
Travere Therapeutics Q3 2026 earnings call: FILSPARI sales rose 120% to $200.2 million, while management maintained its $3 billion 2033 target.